Medical News

RSS

Immune Design begins treatment in LV305 Phase 1 clinical trial for cancer

Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced treatment of the first patient in a Phase 1 clinical trial of LV305, an immuno-oncology investigational agent from the company's DCVexTM lentiviral vector platform.

5 Jun 2014

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.

5 Jun 2014

Advanced Cancer Therapeutics begins clinical trials of PFK-158 small molecule therapeutic candidate

Advanced Cancer Therapeutics, a privately held company dedicated to bringing new anti-cancer therapies to market, announced today (June 4) that it has begun clinical trials of PFK-158, a small molecule therapeutic candidate that inactivates a novel cancer metabolism target never before examined in human clinical trials.

5 Jun 2014

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical launched its Zilver PTX Drug-Eluting Peripheral Stent in Canada at the Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It's the first drug-coated stent in Canada indicated to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA).

From COOK MEDICAL INC. 5 Jun 2014

INTEGRA's VIAFLO 96 handheld multichannel pipette improves efficiency of genetic screening

The Institute of Genetics and Development of Rennes, France reports on how, using a VIAFLO 96 handheld multichannel pipette from INTEGRA, they have been able to improve the efficiency and speed with which they replicate yeast strain collections and perform genetic screens in 96 well plates.

From INTEGRA Biosciences 5 Jun 2014

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Researchers at Shepherd Center are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke.

5 Jun 2014

Many heroin users transitioned from prescription opioids, finds study

A research paper published in the May 28, 2014 issue of JAMA Psychiatry a paper entitled "The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years" concluded that heroin abuse has left low-income urban areas and has become prevalent in more affluent suburbs and rural areas with mostly white populations.

5 Jun 2014

MPS&A launches pilot program to test its Adherence Performance reporting solution

McKesson Pharmacy Systems and Automation (MPS&A) has launched a pilot program to test its Adherence Performance reporting solution.

5 Jun 2014

UST Global receives 'Group Application Services Supplier of the Year' award

UST Global, a leading global IT consulting firm for Global 1000 enterprises, was awarded 'Group Application Services Supplier of the Year' by Alliance Boots.

5 Jun 2014

GPM Pediatrics physician provides treatment, prevention tips on poison ivy

Dr. Michael Gabriel, a Staten Island Pediatrician, provides advice on how to avoid poison ivy plants, and treat or prevent rashes.

5 Jun 2014

Biosafe launches SepaMax multiprocessing device for high throughput cell processing

In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco.

5 Jun 2014

Team Type 1 Foundation awards scholarships to student athletes with type 1 diabetes

The Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, empowerment and equal access to medicine for everyone affected by diabetes, will award $5,000 scholarships to seven student athletes for the 2014-15 academic year as part of the Foundation's inaugural "Global Ambassador Program" recognizing young, talented athletes with type 1 diabetes who are using their sport as a platform to inspire.

5 Jun 2014

$SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus$

SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE).

5 Jun 2014

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that Ruben Mesa, MD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 14, 2014 at the 19th Congress of European Hematology Association (EHA) which is being held in Milan, Italy, from June 12-15, 2014.

5 Jun 2014

Symphony continuous glucose monitoring system study selected for presentation at ADA scientific sessions

Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its most recently completed clinical study of Symphony was selected for poster presentation at the 74th Scientific Sessions of the American Diabetes Association (ADA) which will be held June 13-17, 2014 in San Francisco, CA.

5 Jun 2014

Researchers examine how residential environment impacts birth outcomes in African-Americans

High levels of racial disparities in preterm delivery exist, with African Americans having higher rates than non-Hispanic whites. Since traditional risk factors do not fully account for this disparity, other explanations are needed and researchers at Wayne State University are teaming up to find answers.

5 Jun 2014

First Edition: June 5, 2014

Today's headlines include the latest developments regarding congressional action on the veterans' health care scandal as well as reports about the latest Medicaid enrollment figures in the context of the health law.

5 Jun 2014

RPB grants $500,000 to accelerate treatments for Retinitis Pigmentosa

Research to Prevent Blindness (RPB), the leading eye research foundation, is providing $500,000 to accelerate the development of treatments for Retinitis Pigmentosa (RP) -- a family of retinal diseases that progressively create extreme tunnel vision, loss of night vision and leave affected patients legally blind by the age of 40.

5 Jun 2014

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

5 Jun 2014

Spherix expands its operations in Texas

Spherix Incorporated, an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has expanded its operations in Texas through the opening of a new office located at 222 North Fredonia Street Longview, TX 75601.

5 Jun 2014

Medical News

Immune Design begins treatment in LV305 Phase 1 clinical trial for cancer

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Advanced Cancer Therapeutics begins clinical trials of PFK-158 small molecule therapeutic candidate

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

INTEGRA's VIAFLO 96 handheld multichannel pipette improves efficiency of genetic screening

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Many heroin users transitioned from prescription opioids, finds study

MPS&A launches pilot program to test its Adherence Performance reporting solution

UST Global receives 'Group Application Services Supplier of the Year' award

GPM Pediatrics physician provides treatment, prevention tips on poison ivy

Biosafe launches SepaMax multiprocessing device for high throughput cell processing

Team Type 1 Foundation awards scholarships to student athletes with type 1 diabetes

SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Symphony continuous glucose monitoring system study selected for presentation at ADA scientific sessions

Researchers examine how residential environment impacts birth outcomes in African-Americans

First Edition: June 5, 2014

RPB grants $500,000 to accelerate treatments for Retinitis Pigmentosa

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

Spherix expands its operations in Texas

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News